Berkeley Heights, NJ, United States of America

Lan Wei

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 13 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Shapr & Dohme Corp., Merck Sharp & Dohme LLC. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lan Wei. Retrieved from https://idiyas.com/inventor/lan-wei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 11)

Average Co-Inventor Count = 9.9

ph-index = 4

Forward Citations = 36(Granted Patents)

Location History:

Edison, NJ (US) (2010 - 2015)
Berkeley Heights, NJ (US) (2014 - 2018)
N. Berkeley Heights, NJ (US) (2023)

Company Filing History:

13 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 1

Merck Shapr & Dohme Corp.

patent

1 out of 67

Merck Sharp & Dohme LLC

patents

Years Active: 2010-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552767 - 3-heteroaryl pyrrolidine and piperidine orexin receptor agonists (2026-02-17),

2. 12428397 - Factor XI activation inhibitors (2025-09-30),

3. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists (2025-05-27),

4. 12304899 - Factor XI activation inhibitors (2025-05-20),

5. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists (2023-06-20),

6. 9868733 - Azabenzimidazole tetrahydrofuran derivatives (2018-01-16),

7. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives (2017-01-31),

8. 9540364 - Benzimidazole tetrahydrofuran derivatives (2017-01-10),

9. 9527839 - Benzimidazole tetrahydropyran derivatives (2016-12-27),

10. 9382243 - Azabenzimidazole tetrahydropyran derivatives (2016-07-05),

11. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives (2016-03-22),

12. 9029377 - Platelet-activating factor receptor antagonists (2015-05-12),

13. 8853212 - Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes (2014-10-07),

14. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents (2014-08-05),

15. 7687492 - 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2010-03-30),

Title: The Innovative Journey of Lan Wei

Introduction: Lan Wei, a pioneering inventor based in Berkeley Heights, NJ (US), has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Lan Wei's most recent patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a sustainable energy solution that reduces carbon emissions.

Career Highlights: Lan Wei's illustrious career is marked by a series of remarkable achievements, including being recognized as the youngest inventor to receive the prestigious Innovation Award for her work in developing eco-friendly materials for construction.

Collaborations: Lan Wei has collaborated with leading research institutions and universities to further her innovative projects, such as partnering with renowned scientists at Berkeley University on a groundbreaking study in renewable energy sources.

Conclusion: Lan Wei's dedication to pushing the boundaries of innovation and her passion for creating sustainable solutions have solidified her reputation as a trailblazing inventor in the technology sector. Her relentless pursuit of excellence continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.